1. Home
  2. SKY vs BLTE Comparison

SKY vs BLTE Comparison

Compare SKY & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SKY

Skyline Champion Corporation

HOLD

Current Price

$84.32

Market Cap

4.3B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$150.31

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKY
BLTE
Founded
2010
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SKY
BLTE
Price
$84.32
$150.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$85.00
$149.00
AVG Volume (30 Days)
717.0K
237.0K
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
48.48
N/A
EPS
3.84
N/A
Revenue
$2,624,539,000.00
N/A
Revenue This Year
$5.10
N/A
Revenue Next Year
$4.21
N/A
P/E Ratio
$21.76
N/A
Revenue Growth
12.14
N/A
52 Week Low
$59.44
$49.00
52 Week High
$116.49
$160.55

Technical Indicators

Market Signals
Indicator
SKY
BLTE
Relative Strength Index (RSI) 60.64 70.63
Support Level $75.94 $115.41
Resistance Level $87.17 $160.55
Average True Range (ATR) 2.83 12.38
MACD 0.17 2.23
Stochastic Oscillator 73.25 81.66

Price Performance

Historical Comparison
SKY
BLTE

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: